A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT03671018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03671018
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2024-01-30
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.